化EM揭示了在M5 mAChRR中一个新的全结合部位
Wessel A C Burger1,2,3, Jesse I Mobbs1,2,3, Bhavika Rana1,2,3
1Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia.
bioRxiv : the preprint server for biology
|February 20, 2025
概括
研究人员确定了一个新的结合部位,用于M5肌糖乙胆受体 (M5 mAChR) 阳性全调节剂. 这一发现通过揭示新的全性标,推动了神经系统疾病的药物开发.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 结构生物学 结构生物学
背景情况:
- 肌肉酸乙胆受体M5 (M5 mAChR) 是神经系统疾病的治疗点.
- 药物开发受到M5 mAChR的保守的正经结合部位的挑战.
- 选择性正调节剂 (PAMs) 是潜在的治疗药物,但它们的结合部位尚不清楚.
研究的目的:
- 为了结构性地描述M5 mAChR.的活跃状态.
- 为了确定M5-选择性PAMs的全结合部位.
- 了解M5 mAChR.中全性调节的机制.
主要方法:
- 低温电子显微镜 (cryo-EM) 用于确定M5 mAChR结构.
- 变异性研究探讨全位功能.
- 药理分析和分子动力学模拟以验证结合位点.
主要成果:
- 获得了活性M5 mAChR-Gq复合物的2.8 Å冷-EM结构.
- M5选择性PAMs与已知位点不同的一种新型全位点结合.
- 一个2.1 Å的冷EM结构揭示了M5 mAChR与乙胆结合,以及在一个新的口袋中的选择性PAM (VU6007678).
结论:
- 对M5 mAChR PAMs的一种新型全结合口袋在跨膜域3/4接口上被确定.
- 这一发现为M5 mAChR全调节提供了关键的结构见解.
- 这些发现凸显了药物发现的综合结构和药理学方法的有用性.
更多相关视频
09:25Do's and Don'ts of Cryo-electron Microscopy: A Primer on Sample Preparation and High Quality Data Collection for Macromolecular 3D Reconstruction
Published on: January 9, 2015
46.0K
12:27A Pipeline to Investigate the Structures and Signaling Pathways of Sphingosine 1-Phosphate Receptors
Published on: June 8, 2022
3.3K
相关概念视频
Allosteric Proteins-ATCase
5.6K
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
5.6K
Allosteric Regulation
57.5K
Allosteric regulation of enzymes occurs when the binding of an effector molecule to a site that is different from the active site causes a change in the enzymatic activity. This alternate site is called an allosteric site, and an enzyme can contain more than one of these sites. Allosteric regulation can either be positive or negative, resulting in an increase or decrease in enzyme activity. Most enzymes that display allosteric regulation are metabolic enzymes involved in the degradation or...
57.5K
Ligand Binding and Linkage
4.7K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
4.7K
Cholinergic Receptors: Muscarinic
1.8K
The pharmacological actions of acetylcholine are elicited via its binding to two families of cholinergic receptors or cholinoceptors, namely, muscarinic and nicotinic receptors. Muscarinic receptors are G protein-coupled receptors and have five subtypes, M1–M5. All mAChR subtypes are activated by acetylcholine and blocked by the antagonist, atropine.
The subtypes M1, M3, and M5 couple with the Gq subunit and activate the phospholipase C (PLC) activity, mobilizing intracellular Ca2+....
The subtypes M1, M3, and M5 couple with the Gq subunit and activate the phospholipase C (PLC) activity, mobilizing intracellular Ca2+....
1.8K
Cooperative Allosteric Transitions
7.8K
Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...
7.8K
Cryo-electron Microscopy
3.2K
Conventional electron microscopy (EM) involves dehydration, fixation, and staining of biological samples, which distorts the native state of biological molecules and results in several artifacts. Also, the high-energy electron beam damages the sample and makes it difficult to obtain high-resolution images. These issues can be addressed using cryo-EM, which uses frozen samples and gentler electron beams. The technique was developed by Jacques Dubochet, Joachim Frank, and Richard Henderson, for...
3.2K
